Diadexus, Inc.
company.status.inactiveCIK 1036968fmd_0QJPRC8EADTXK12ZPJ6SQW2ZXCManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2016, 24 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|
| Total revenues | 12 | 16 | 21 | 25 | 26 | 18 |
| Cost of revenue | 5 | 5 | 6 | 7 | 7 | 5 |
| Gross profit | 7 | 11 | 14 | 18 | 20 | 13 |
| Research and development | 5 | 5 | 4 | 5 | 6 | 4 |
| Selling, general and administrative | 11 | 14 | 13 | 15 | 20 | 13 |
| Operating income | (9) | (8) | (2) | (2) | (7) | (5) |
| Interest expense | 0 | (0) | 0 | 0 | 2 | 2 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | 0 | (0) | 0 | 0 | (0) |
| Income before taxes | (9) | (7) | (3) | (2) | (8) | (7) |
| Income tax expense | (0) | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (8) | (7) | (3) | (2) | (8) | (7) |
| Net income | (8) | (7) | (3) | (2) | (8) | (7) |